IL91304A0 - Recombinant vaccinia virus for prevention of disease caused by flavivirus - Google Patents

Recombinant vaccinia virus for prevention of disease caused by flavivirus

Info

Publication number
IL91304A0
IL91304A0 IL91304A IL9130489A IL91304A0 IL 91304 A0 IL91304 A0 IL 91304A0 IL 91304 A IL91304 A IL 91304A IL 9130489 A IL9130489 A IL 9130489A IL 91304 A0 IL91304 A0 IL 91304A0
Authority
IL
Israel
Prior art keywords
flavivirus
prevention
vaccinia virus
disease caused
recombinant vaccinia
Prior art date
Application number
IL91304A
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL91304A0 publication Critical patent/IL91304A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL91304A 1988-08-20 1989-08-14 Recombinant vaccinia virus for prevention of disease caused by flavivirus IL91304A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23920588A 1988-08-20 1988-08-20

Publications (1)

Publication Number Publication Date
IL91304A0 true IL91304A0 (en) 1990-03-19

Family

ID=22901085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91304A IL91304A0 (en) 1988-08-20 1989-08-14 Recombinant vaccinia virus for prevention of disease caused by flavivirus

Country Status (5)

Country Link
EP (1) EP0431064A4 (en)
JP (1) JPH03503364A (en)
AU (1) AU624863B2 (en)
IL (1) IL91304A0 (en)
WO (1) WO1990001946A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6676936B1 (en) 1988-07-14 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services. Chimeric and/or growth-restricted flaviviruses
US6184024B1 (en) 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
DD297997A5 (en) * 1989-06-06 1992-01-30 @��@����@��������`������������@��������k�� PROTEINS, VACCINE AND NUCLEIC ACIDS
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
ES2153223T3 (en) * 1991-09-19 2001-02-16 Us Health CHIMERIC FLAVIVIRUS AND / OR RESTRICTED GROWTH FLAVIVIRUS.
US6117640A (en) * 1995-05-02 2000-09-12 The United States Of America As Represented By The Secretary Of The Army Recombinant vaccine made in E. coli against dengue virus
CA2224724C (en) * 1995-05-24 2007-12-04 Hawaii Biotechnology Group, Inc. Subunit vaccine against flavivirus infection
EP0951555A2 (en) 1996-09-24 1999-10-27 Bavarian Nordic Research Institute A/S Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
JP4504464B2 (en) * 1997-02-28 2010-07-14 サノフィ パスツール バイオロジクス カンパニー Chimeric flavivirus vaccine
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
AU778988B2 (en) 1998-06-04 2004-12-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Nucleic acid vaccines for prevention of flavivirus infection
CA2941182A1 (en) 2000-02-16 2001-08-23 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Avirulent, immunogenic flavivirus chimeras
EP2345665A3 (en) * 2001-12-04 2012-02-15 Bavarian Nordic A/S Flavivirus NS1 subunit vaccine
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
CN113637694A (en) 2013-03-15 2021-11-12 武田疫苗股份有限公司 Compositions and methods for dengue virus chimeric constructs in vaccines
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
ES2908304T3 (en) 2018-09-05 2022-04-28 Takeda Vaccines Inc Unit dose of dengue vaccine and its administration
JP7554423B2 (en) * 2019-03-14 2024-09-20 公益財団法人東京都医学総合研究所 Dengue vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH084508B2 (en) * 1987-09-16 1996-01-24 国立予防衛生研究所長 Recombinant vaccinia virus

Also Published As

Publication number Publication date
JPH03503364A (en) 1991-08-01
EP0431064A4 (en) 1991-11-13
AU624863B2 (en) 1992-06-25
EP0431064A1 (en) 1991-06-12
WO1990001946A1 (en) 1990-03-08
AU4206489A (en) 1990-03-23

Similar Documents

Publication Publication Date Title
EP0431064A4 (en) Recombinant vaccinia virus for prevention of disease caused by flavivirus
GB2217718A (en) Recombinant avipox virus
GB8821528D0 (en) Recombinant vaccinia virus
ATA902590A (en) RECOMBINANT SMALL VIRUS
ATA257190A (en) VIRAL POLYPEPTIDE
DK603888A (en) RECOMBINANT VIRUS
IT1239987B (en) SPECTRUM SELECTION SYSTEM OF INFECTIVITY OF RECOMBINANT POXVIRUS
NO892251D0 (en) PROCEDURE FOR THE PREPARATION OF COCOCOIDOSE VACCINE BY RECOMBINANT TECHNIQUES.
ZM9387A1 (en) Treatment of diseases caused by viruses
HU912526D0 (en) Recombinant marek-type disease virus
EP0210931A3 (en) Vaccine against varicella-zoster virus
DK197989D0 (en) peptide analogs
EP0400065A4 (en) Lhrh analogs
IL89601A0 (en) Expression vectors containing a recombinant vaccinia virus
EP0450100A4 (en) Physiologically active peptide
GB8716953D0 (en) Restricting movement of lever
GB8916391D0 (en) Preparation of polyacetals
ITMI931371A0 (en) PROCEDURE FOR THE PREPARATION OF ERDOSTEINE
EP0428103A3 (en) Prevention of glycoprotein enveloped virus infectivity by pyridyloxazole-2-ones
EP0417825A3 (en) Cymenol preparation by direct dehydrogenation
GB8819884D0 (en) Syringe for preparation of casting patterns
GB8914680D0 (en) Prevention of aid virus
ITMI910861A0 (en) IMPROVED PROCEDURE FOR THE PREPARATION OF MATURE POLYPEPTIDES
IL84541A0 (en) Pharmaceutical composition for treating a disease caused by virus
IE870898L (en) Recombinant vaccinia virus.